Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medifast offers clinically proven weight loss and health programs primarily through its Optavia brand. The company has impacted millions of lives with evidence-based meal replacement plans supported by independent coaches. In late 2023, Medifast expanded into medically supported weight loss by partnering with LifeMD to offer prescription GLP‑1 medications alongside its behavioral/lifestyle interventions. No clinical trial pipeline as in pharma companies.
Clinical results from university studies have shown effectiveness for weight loss using their portion-controlled meal replacement approach. The new medically supported offering includes access to board-certified clinicians for prescription therapies where appropriate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medifast.